1. Home
  2. ASNS vs CHRO Comparison

ASNS vs CHRO Comparison

Compare ASNS & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • CHRO
  • Stock Information
  • Founded
  • ASNS 1998
  • CHRO 2002
  • Country
  • ASNS United States
  • CHRO United States
  • Employees
  • ASNS N/A
  • CHRO N/A
  • Industry
  • ASNS Telecommunications Equipment
  • CHRO
  • Sector
  • ASNS Telecommunications
  • CHRO
  • Exchange
  • ASNS Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • ASNS 9.8M
  • CHRO 10.7M
  • IPO Year
  • ASNS 2022
  • CHRO 2024
  • Fundamental
  • Price
  • ASNS $0.72
  • CHRO $1.45
  • Analyst Decision
  • ASNS Strong Buy
  • CHRO Strong Buy
  • Analyst Count
  • ASNS 1
  • CHRO 1
  • Target Price
  • ASNS $5.00
  • CHRO N/A
  • AVG Volume (30 Days)
  • ASNS 401.9K
  • CHRO 8.2K
  • Earning Date
  • ASNS 03-24-2025
  • CHRO 03-27-2025
  • Dividend Yield
  • ASNS N/A
  • CHRO N/A
  • EPS Growth
  • ASNS N/A
  • CHRO N/A
  • EPS
  • ASNS N/A
  • CHRO N/A
  • Revenue
  • ASNS $7,760,000.00
  • CHRO N/A
  • Revenue This Year
  • ASNS $31.44
  • CHRO N/A
  • Revenue Next Year
  • ASNS $54.00
  • CHRO N/A
  • P/E Ratio
  • ASNS N/A
  • CHRO N/A
  • Revenue Growth
  • ASNS 38.42
  • CHRO N/A
  • 52 Week Low
  • ASNS $0.36
  • CHRO $0.45
  • 52 Week High
  • ASNS $4.60
  • CHRO $3.80
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 35.60
  • CHRO 43.38
  • Support Level
  • ASNS $0.69
  • CHRO $1.34
  • Resistance Level
  • ASNS $1.04
  • CHRO $2.00
  • Average True Range (ATR)
  • ASNS 0.13
  • CHRO 0.17
  • MACD
  • ASNS -0.02
  • CHRO -0.02
  • Stochastic Oscillator
  • ASNS 5.75
  • CHRO 16.58

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The Company operates as one operating segment developing and marketing access broadband equipment for copper and fiber networks.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: